| Old Articles: <Older 1051-1060 Newer> |
|---|
 |
Chemistry World
June 14, 2006
Simon Hadlington |
Natural Metabolism of Fluorine Scientists have isolated a cluster of bacterial genes responsible for the biochemical processing of fluorine. The research follows the discovery of a unique enzyme that incorporates inorganic fluoride into organic metabolites.   |
Bio-IT World
June 2006
Mark D. Uehling |
Real-Time Trials Currently, there is more visibility into the precise location of a FedEx package than the progress of a multimillion-dollar clinical drug trial. But adaptive design trials are changing that. |
Bio-IT World
June 2006
John Russell |
Gilna to Captain CAMERA Later this summer researchers will gain access to version 0.5 of CAMERA (the Community Cyberinfrastructure for Advanced Marine Microbial Ecology Research and Analysis) a platform replete with a wealth of data, analysis tools, and high-speed computational infrastructure. |
Bio-IT World
June 2006 |
3rd Millennium Goes Out on a LIMS Commercial laboratory information systems have a bad reputation. Conventional wisdom is they are expensive and too rigid. Now, a small previously consulting-only company is changing that with their award-winning offering for microarray research. |
Bio-IT World
June 2006
Alan S. Louie |
Semantic Web at the Cusp of Reality Even with successful development of standards and access to the Semantic Web infrastructure, Semantic Web technology overall will not be successful without broad acceptance and adoption by the drug development industry. |
Bio-IT World
June 2006
Graeme O'Neill |
Why Variety Is the Spice of Life In an effort to bring order to the field of single nucleotide polymorphism research data collection and management, pioneering mutation hunter Richard Cotton has organized The Human Variome Project Meeting in Melbourne, Australia. |
Bio-IT World
June 2006
Mark D. Uehling |
Afferenz on EDC, Images, and Data Integration There are people who think the outsourcing of IT to India will not affect the life sciences. But companies like Afferenz raises concerns about U.S. companies lagging behind Indian companies on laying the foundation for clinical trials. |
Bio-IT World
June 2006
Kevin Davies |
HapMap Project Prepares for Phase II Release The official release of the Phase II HapMap data will provide a publicly available trove of information on human genetic variation across populations that will reveal insights into the genetic basis of human disease and individual response to pharmaceuticals. |
Bio-IT World
June 2006
Robert M. Frederickson |
Tissue Microarray Hard and Software Technological advances in automated microscopes, digital image acquisition, and high-throughput screening techniques have led to the need for more sophisticated software tools, now offered through a collaboration between DMetrix, BioImagene, IBM and the Arizona Cancer Center. |
Bio-IT World
June 2006
Kevin Davies |
David Shaw: No Hedging on Future of Computer Simulations The computational scientist who founded the world's largest alternative investment firm says he is two years away from building a new breed of computer that could be a major breakthrough in structural biology -- simulating the process of protein folding and protein-drug interactions. |
| <Older 1051-1060 Newer> Return to current articles. |
